An update on retinal laser therapy

Clinical and Experimental Optometry

Volumn 94, Issue 1, 2011, Pages 43-51

  Lock, Jane Huan Jing ^a   Fong, Kenneth Choong Sian ^b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Laser coagulation; Laser therapy; Retinal diseases; Retinal pigments

Indexed keywords

CLASSIFICATION; HUMAN; INSTRUMENTATION; LASER; LASER COAGULATION; LOW LEVEL LASER THERAPY; RETINA DISEASE; REVIEW;

HUMANS; LASER THERAPY; LASERS; LIGHT COAGULATION; RETINAL DISEASES;

EID: 78650693940     PISSN: 08164622     EISSN: 14440938     Source Type: Journal    
DOI: 10.1111/j.1444-0938.2010.00529.x     Document Type: Review

References (58)

1. Meyer-Schwickerath GR. The history of photocoagulation. Aust N Z J Ophthalmol 1989; 17: 427-434.
2. Ober MD, Hariprasad SM. Retinal lasers: Past, present and future. Ret Physician 2009; 6: 36-39.
3. L'Esperance FA Jr. An opthalmic argon laser photocoagulation system: design, construction, and laboratory investigations. Trans Am Ophthalmol Soc 1968; 66: 827-904.
4. Krauss JM, Puliafito CA. Lasers in ophthalmology. Lasers Surg Med 1995; 17: 102-159.
5. Balles MW, Puliafito CA. Semiconductor diode lasers: a new laser light source in ophthalmology. Int Ophthalmol Clin 1990; 30: 77-83.
6. Moriarty AP. Diode lasers in ophthalmology. Int Ophthalmol 1993; 17: 297-304.
7. Pratesi R. Diode lasers in photomedicine. J Quant Electron 1984; 20: 1433-1439.
8. Puliafito CA, Deutsch TF, Boll J, To K. Semiconductor laser endophotocoagulation of the retina. Arch Ophthalmol 1987; 105: 424-427.
9. Kulkarni GR. Laser-tissue interaction studies for medicine. Bull Material Sci 1988; 11: 239-244.
10. O'Neill D, Gregson R, McHugh D. Current uses of ophthalmic lasers. BMJ 1992; 304: 1161-1165.
11. Mainster MA. Decreasing retinal photocoagulation damage: principles and techniques. Semin Ophthalmol 1999; 14: 200-209.
12. Suomalainen VP. Comparison of retinal lesions produced by transscleral krypton laser photocoagulation, transpupillar krypton laser photocoagulation and cryocoagulation. Acta Ophthalmol Scand 1993; 71: 224-229.
13. Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol 2009; 54: 1-32.
14. Stefansson E. The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand 2001; 79: 435-440.
15. Gottfredsdottir MS, Stefansson E, Jonasson F, Gislason I. Retinal vasoconstriction after laser treatment for diabetic macular edema. Am J Ophthalmol 1993; 115: 64-67.
16. Ishida K, Yoshimura N, Yoshida M, Honda Y. Upregulation of transforming growth factor-beta after panretinal photocoagulation. Invest Ophthalmol Vis Sci 1998; 39: 801-807.
17. Matsumoto M, Yoshimura N, Honda Y. Increased production of transforming growth factor-beta 2 from cultured human retinal pigment epithelial cells by photocoagulation. Invest Ophthalmol Vis Sci 1994; 35: 4245-4252.
18. Ogata N, Ando A, Uyama M, Matsumura M. Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol 2001; 239: 87-95.
19. Dyer DS, Bressler SB, Bressler NM. The role of laser wavelength in the treatment of vitreoretinal diseases. Curr Opin Ophthalmol 1994; 5: 35-43.
20. Parver LM. Photochemical injury to the foveomacula of the monkey eye following argon blue-green panretinal photocoagulation. Trans Am Ophthalmol Soc 2000; 98: 365-374.
21. Freeman WR, Bartsch DU. New ophthalmic lasers for the evaluation and treatment of retinal disease. Aust N Z J Ophthalmol 1993; 21: 139-146.
22. Swartz M. Histology of macular photocoagulation. Ophthalmology 1986; 93: 959-963.
23. Castillejos-Rios D, Devenyi R, Moffat K, Yu E. Dye yellow vs. argon green laser in panretinal photocoagulation for proliferative diabetic retinopathy: a comparison of minimum power requirements. Can J Ophthalmol 1992; 27: 243-244.
24. Mainster MA. Wavelength selection in macular photocoagulation. Tissue optics, thermal effects, and laser systems. Ophthalmology 1986; 93: 952-958.
25. Fankhauser F 2nd, Giger H, Niederer P, Seiler T. Transpupillary laser phototherapy of tumors and vascular anomalies of retina and choroid: theoretical approach and clinical implications. Technol Health Care 2000; 8: 93-112.
26. Berger JW. Thermal modelling of micropulsed diode laser retinal photocoagulation. Lasers Surg Med 1997; 20: 409-415.
27. Bandello F, Pognuz R, Polito A, Pirracchio A, Menchini F, Ambesi M. Diabetic macular edema: classification, medical and laser therapy. Semin Ophthalmol 2003; 18: 251-258.
28. Schatz H, Madeira D, McDonald HR, Johnson RN. Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Arch Ophthalmol 1991; 109: 1549-1551.
29. Roider J, Hillenkamp F, Flotte T, Birngruber R. Microphotocoagulation: selective effects of repetitive short laser pulses. Proc Natl Acad Sci USA 1993; 90: 8643-8647.
30. Pollack JS, Kim JE, Pulido JS, Burke JM. Tissue effects of subclinical diode laser treatment of the retina. Arch Ophthalmol 1998; 116: 1633-1639.
31. Dorin G. Subthreshold and micropulse diode laser photocoagulation. Semin Ophthalmol 2003; 18: 147-153.
32. Sanghvi C, McLauchlan R, Delgado C, Young L, Charles SJ, Marcellino G, Stanga PE. Initial experience with the Pascal photocoagulator: a pilot study of 75 procedures. Br J Ophthalmol 2008; 92: 1061-1064.
33. Diabetic Retinopathy Clinical Research Network, Beck RW, Edwards AR, Aiello LP, Bressler NM, Ferris F, Glassman AR, Hartnett E et al. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol 2009; 127: 245-251.
34. Diabetic Retinopathy Clinical Research Network, Scott IU, Edwards AR, Beck RW, Bressler NM, Chan CK, Elman MJ, Friedman SM et al. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 2007; 114: 1860-1867.
35. Soheilian M, Ramezani A, Obudi A, Bijanzadeh B, Salehipour M, Yaseri M, Ahmadieh H et al. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema. Ophthalmology 2009; 116: 1142-1150.
36. Mirshahi A, Shenazandi H, Lashay A, Faghihi H, Alimahmoudi A, Dianat S. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema. Retina 2010; 30: 254-259.
37. Maia OO Jr, Takahashi BS, Costa RA, Scott IU, Takahashi WY. Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial. Am J Ophthalmol 2009; 147: 291-297.
38. Margolis R, Singh RP, Bhatnagar P, Kaiser PK. Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema. Acta Ophthalmol Scand 2008; 86: 105-110.
39. Lam DSC, Chan CKM, Mohamed S, Lai TYY, Lee VYW, Liu DTL, Li KKW et al. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes. Ophthalmology 2007; 114: 2162-2167.
40. Bessette FM, Nguyen LC. Laser light: its nature and its action on the eye. CMAJ 1989; 141: 1141-1148.
41. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology 1981; 88: 583-600.
42. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985; 103: 1796-1806.
43. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Macular Photocoagulation Study Group. Arch Ophthalmol 1994; 112: 480-488.
44. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1982; 100: 912-918.
45. Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol 1986; 104: 694-701.
46. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol 1993; 111: 1200-1209.
47. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol 1991; 109: 1232-1241.
48. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol 1991; 109: 1220-1231.
49. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol 1991; 109: 1109-1114.
50. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group. Arch Ophthalmol 1994; 112: 489-499.
51. Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. Am J Ophthalmol 1984; 98: 271-282.
52. McAllister IL, Constable IJ. Laser-induced chorioretinal venous anastomosis for treatment of non-ischemic central retinal vein occlusion. Arch Ophthalmol 1995; 113: 456-462.
53. McNamara JA, Tasman W, Vander JF, Brown GC. Diode laser photocoagulation for retinopathy of prematurity. Preliminary results. Arch Ophthalmol 1992; 110: 1714-1716.
54. McNamara JA, Tasman W, Brown GC, Federman JL. Laser photocoagulation for stage 3+ retinopathy of prematurity. Ophthalmology 1991; 98: 576-580.
55. Dehghan MH, Ahmadieh H, Soheilian M, Azarmina M, Mashayekhi A, Naghibozakerin J. Therapeutic effects of laser photocoagulation and/or vitrectomy in Eales' disease. Eur J Ophthalmol 2005; 15: 379-383.
56. Atmaca LS, Batioglu F, Idil A. Retinal and disc neovascularization in Behçet's disease and efficacy of laser photocoagulation. Graefes Arch Clin Exp Ophthalmol 1996; 234: 94-99.
57. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report. Ophthalmology 1995; 102: 1434-1444.
58. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group. Arch Ophthalmol 1986; 104: 34-41.